A detailed history of Victory Capital Management Inc transactions in Alector, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 156,234 shares of ALEC stock, worth $710,864. This represents 0.0% of its overall portfolio holdings.

Number of Shares
156,234
Previous 129,140 20.98%
Holding current value
$710,864
Previous $777,000 8.75%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$4.19 - $6.23 $113,523 - $168,795
27,094 Added 20.98%
156,234 $709,000
Q1 2024

May 03, 2024

BUY
$5.69 - $8.08 $21,326 - $30,283
3,748 Added 2.99%
129,140 $777,000
Q4 2023

Feb 05, 2024

SELL
$3.77 - $8.39 $35,159 - $78,245
-9,326 Reduced 6.92%
125,392 $1 Million
Q3 2023

Nov 06, 2023

SELL
$5.2 - $8.77 $76,778 - $129,489
-14,765 Reduced 9.88%
134,718 $872,000
Q2 2023

Jul 27, 2023

SELL
$5.86 - $7.93 $217,874 - $294,837
-37,180 Reduced 19.92%
149,483 $898,000
Q1 2023

May 02, 2023

BUY
$5.85 - $9.84 $116,865 - $196,573
19,977 Added 11.98%
186,663 $1.16 Million
Q4 2022

Feb 10, 2023

SELL
$6.88 - $9.55 $128,463 - $178,317
-18,672 Reduced 10.07%
166,686 $1.54 Million
Q4 2022

Feb 09, 2023

BUY
$6.88 - $9.55 $1.2 Million - $1.66 Million
173,727 Added 1493.65%
185,358 $1.71 Million
Q3 2022

Nov 02, 2022

BUY
$8.19 - $13.2 $95,257 - $153,529
11,631 New
11,631 $110,000
Q1 2021

May 04, 2021

SELL
$14.84 - $22.23 $149,720 - $224,278
-10,089 Closed
0 $0
Q4 2020

Feb 01, 2021

BUY
$9.4 - $16.7 $94,836 - $168,486
10,089 New
10,089 $153,000
Q2 2020

Aug 07, 2020

SELL
$21.87 - $33.11 $148,912 - $225,445
-6,809 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$16.25 - $35.28 $11,131 - $24,166
-685 Reduced 9.14%
6,809 $164,000
Q4 2019

Feb 06, 2020

BUY
$14.17 - $20.3 $11,137 - $15,955
786 Added 11.72%
7,494 $129,000
Q4 2019

Feb 04, 2020

BUY
$14.17 - $20.3 $21,240 - $30,429
1,499 Added 28.78%
6,708 $187,000
Q3 2019

Nov 12, 2019

BUY
$14.42 - $22.2 $75,113 - $115,639
5,209 New
5,209 $75,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $376M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.